Skip to content

Released Nov 14, 2011, during market hours

10-Q filed Nov 14, 2011, 45 days after period end · 0000950123-11-098294

Q3 2011 · 10-Q
Revenue—
Net Income-$5.48MN/M vs Q3 2010N/M vs Q2 2011
EPS Diluted-$0.14N/M vs Q3 2010N/M vs Q2 2011
Operating Cash Flowderived-$3,413,000N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2011Q3 2010
Net Income-$5.48M-$4.14M
EPS Diluted-$0.14-$0.23

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR